ロード中...
Recent progress concerning CpG DNA and its use as a vaccine adjuvant
CpG Oligonucleotides (ODN) are immunomodulatory synthetic oligonucleotides designed to specifically agonize Toll-like receptor 9. Here, we review recent progress in understanding the mechanism of action of CpG ODN and provide an overview of human clinical trial results using CpG ODN to improve the v...
保存先:
| 出版年: | Expert Rev Vaccines |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6335645/ https://ncbi.nlm.nih.gov/pubmed/24308579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2014.863715 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|